Lars Jenne
Overview
Explore the profile of Lars Jenne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luftl M, Sauter-Jenne B, Gramatzki M, Eckert F, Jenne L
J Dtsch Dermatol Ges
. 2010 Mar;
8(12):1000-3.
PMID: 20202045
A 43-year-old healthy patient developed disseminated flat skin-colored to red-brown papules over a few months. These papules were the result of cutaneous IgM deposits representing the first symptom of a...
2.
Humrich J, Thumann P, Greiner S, Humrich J, Averbeck M, Schwank C, et al.
Eur J Immunol
. 2007 Mar;
37(4):954-65.
PMID: 17357104
A crucial event for the induction of an anti-viral immune response is the coordinated, phenotype-dependent migration of dendritic cells (DC) to sites of infection and secondary lymphoid organs. Here we...
3.
Humrich J, Humrich J, Averbeck M, Thumann P, Termeer C, Kampgen E, et al.
Immunology
. 2006 Jan;
117(2):238-47.
PMID: 16423060
The chemokine receptor CCR7 is crucial for migration of mature dendritic cells (DC) directed toward secondary lymphoid organs; however, there is little knowledge about the function of the homeostatic chemokine...
4.
Schultz E, Schuler-Thurner B, Stroobant V, Jenne L, Berger T, Thielemanns K, et al.
J Immunol
. 2004 Jan;
172(2):1304-10.
PMID: 14707109
Recently, we have demonstrated that tumor-specific CD4+ Th cell responses can be rapidly induced in advanced melanoma patients by vaccination with peptide-loaded monocyte-derived dendritic cells. Most patients showed a T...
5.
Thumann P, Moc I, Humrich J, Berger T, Schultz E, Schuler G, et al.
J Immunol Methods
. 2003 Jun;
277(1-2):1-16.
PMID: 12799035
Dendritic cells (DC) based vaccinations have been widely used for the induction of anti-tumoral immunity in clinical studies. Antigen loading of DC with whole tumor cell preparations is an attractive...
6.
Jenne L, Steinkasserer A
Arch Immunol Ther Exp (Warsz)
. 2002 Oct;
50(4):273-7.
PMID: 12371623
An alternative approach to the use of tumor-peptide-loaded dendritic cells (DC) in immunotherapy would be the use of genetically modified DC using viral vectors expressing tumor-associated antigens (TAA). However, viruses...